Corporate News Report
Inoviq Ltd (IIQ.AX) – 24‑Hour Performance Summary
Trading Activity
The share price increased by 3.85 % during the 24‑hour period ending at 11:22 AM Central Europe on Monday, 26 January 2026.
Current trading price: AUD 0.14.
Trading volume in the last 24 hours: AUD 18 000.
Market capitalization: AUD 19 million.
Outstanding shares: 140.7 million.
Historical Price Context
200‑day simple moving average: AUD 0.28.
52‑week high: AUD 0.56 (recorded 23 June 2026).
52‑week low: AUD 0.13 (recorded 23 October 2026).
Since the end of last month, the share price has declined 25 %.
Recent Corporate Actions
No corporate actions or dividend announcements were reported for the period under review.
Performance of Related Australian Securities
| Ticker | 24‑Hour Change | Current Price | Market Capitalisation | Notes |
|---|---|---|---|---|
| AAU.AX (Antilles Gold) | 0 % | AUD 0.01 | AUD 22.7 million | No price change. |
| PKP.AX (Peak Processing) | 0 % | AUD 0.02 | AUD 22.8 million | No price change. |
| PWN.AX (Parkway Corporate) | 0 % | AUD 0.01 | AUD 22.2 million | No price change. |
| HVY.AX (Heavy Minerals) | +1.67 % | AUD 0.29 | AUD 22.4 million | Modest gain. |
| VKA.AX (Viking Mines) | –5.26 % | AUD 0.01 | AUD 22.6 million | Decline accompanied by operational update (see below). |
Viking Mines (VKA.AX) – Operational Update
Viking Mines Limited released a progress report regarding its Nevada tungsten portfolio. Key points include:
- Drilling Results: The maiden drilling campaign at the Linka Project produced significant tungsten intercepts, confirming the presence of tungsten beneath historic workings.
- Metallurgical Testing: Ore‑sorting tests from TOMRA showed that Linka material can be upgraded to high‑grade products. A bulk‑sample approval from the BLM will enable toll‑treatment for further concentrate production.
- Divestment: The company completed a divestment of its First Hit Gold Project, generating cash and shares, and maintains a healthy cash position.
- Future Plans: Planned activities for the upcoming quarter include completing the remaining drilling program, refining the 3‑D geological model, advancing metallurgical optimisation, continuing exploration at secondary Nevada sites, and reviewing potential acquisitions.
About Inoviq Ltd
Inoviq Ltd is a biotechnology company headquartered in Notting Hill, Australia. The company focuses on developing and commercializing diagnostic and exosome‑based products for cancer and other disease diagnostics. Inoviq’s services are currently limited to the Australian market. Additional information is available on the company’s website at www.inoviq.com . The stock trades on the ASX All Markets under the ticker IIQ.AX.
